TG Therapeutics reported $2K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US USD 2K 21K
Abbvie ABBV:US USD 5.02B 880M
Amgen AMGN:US USD 1.59B 78M
Ardelyx ARDX:US USD 732K 594K
Bayer BAYN:GR EUR 4.25B 1.43B
Biogen BIIB:US USD 469.5M 14.5M
Corcept Therapeutics CORT:US USD 1.34M 23K
Curis CRIS:US USD 62K 20K
Dynavax Technologies DVAX:US USD 61.33M 22.04M
Gilead Sciences GILD:US USD 1.4B 47M
Infinity Pharmaceuticals INFI:US USD 429K 15K
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Johnson & Johnson JNJ:US USD 7.81B 95M
Karyopharm Therapeutics KPTI:US USD 980K 41K
Novartis NOVN:VX USD 3.66B 92M
Novavax NVAX:US USD 434.59M 163.52M
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M